These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 3109733)
1. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice. Kruszewski FH; Conti CJ; DiGiovanni J Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733 [TBL] [Abstract][Full Text] [Related]
2. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of mouse skin tumor promotion by chrysarobin. DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797 [TBL] [Abstract][Full Text] [Related]
4. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
5. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
6. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice. Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents. DiGiovanni J; Walker SC; Beltran L; Naito M; Eastin WC Cancer Res; 1991 Mar; 51(5):1398-405. PubMed ID: 1900038 [TBL] [Abstract][Full Text] [Related]
8. Promoter independence as a feature of most skin papillomas in SENCAR mice. Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044 [TBL] [Abstract][Full Text] [Related]
9. Tumor promotion by a hydroperoxide metabolite of butylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone, in mouse skin. Taffe BG; Kensler TW Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):291-303. PubMed ID: 3141995 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302 [TBL] [Abstract][Full Text] [Related]
11. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
12. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin. Bhasin G; Kauser H; Athar M Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284 [TBL] [Abstract][Full Text] [Related]
13. Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skin. Leyton J; Lee ML; Locniskar M; Belury MA; Slaga TJ; Bechtel D; Fischer SM Cancer Res; 1991 Feb; 51(3):907-15. PubMed ID: 1899048 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis. Yokota K; Gill TJ; Shinozuka H Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029 [TBL] [Abstract][Full Text] [Related]
16. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020 [TBL] [Abstract][Full Text] [Related]
18. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Meeran SM; Vaid M; Punathil T; Katiyar SK Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151 [TBL] [Abstract][Full Text] [Related]